Related Experiment Video

Updated: Jun 2, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Activation of the PI3K-AKT pathway in human malignant mesothelioma cells

Yutaro Suzuki1, Hideki Murakami, Koji Kawaguchi

  • 1Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.

Molecular Medicine Reports
|April 9, 2011
PubMed

Insights

Phosphatidylinositol 3-kinase (PI3K)-AKT pathway activation is common in malignant mesothelioma (MM). PTEN inactivation, a tumor suppressor, contributes to this activation, suggesting PI3K-AKT is a potential therapeutic target for MM.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Malignant mesothelioma (MM) is an aggressive cancer linked to asbestos exposure.
  • The phosphatidylinositol 3-kinase (PI3K)-AKT pathway is crucial for cancer cell growth and survival.
  • Understanding PI3K-AKT pathway dysregulation in MM is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the activation status of the PI3K-AKT pathway in MM cells.
  • To identify the mechanisms driving PI3K-AKT pathway activation in MM.
  • To evaluate PTEN's role in PI3K-AKT pathway dysregulation in MM.

Main Methods:

  • Analysis of PI3K-AKT pathway activation in 21 MM cell lines.
  • Assessment of PTEN (phosphatase and tensin homolog) expression and genetic alterations.
  • Evaluation of PIK3CA and LKB1 mutations.
  • In vitro colony formation assays after PTEN re-expression.

Main Results:

  • AKT activation was detected in 62% of MM cell lines under serum-starved conditions.
  • PTEN expression was downregulated or absent in several MM cell lines due to genetic deletions.
  • Re-expression of PTEN reduced colony formation in MM cells.
  • No PIK3CA or LKB1 mutations were identified in the studied MM cell lines.

Conclusions:

  • AKT is frequently activated in malignant mesothelioma, partly due to PTEN downregulation.
  • PTEN inactivation is a key mechanism driving PI3K-AKT pathway activation in MM.
  • The PI3K-AKT signaling pathway represents a promising therapeutic target for MM treatment.

More Related Videos

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...